Substance Use-related Co-morbidities and Health-related Outcomes

Release Date:

February 24, 2012; reviewed November 21, 2016

Scope of Collection

Element Considered	Final Measures in Toolkit
Additional clinical considerations (intervention, prevention including type of treatment, success & relapse) specific to certain drugs	Duration of Abstinence - Alcohol
	Duration of Abstinence - Substance Use
Medical and psychiatric comorbidities	Behavioral Health Screener
	Victimization Screener
HIV/AIDS & risk behaviors	Comprehensive HIV Risk Assessment
Treatment history	Substance Abuse Treatment, Participation, and Involvement
	Self-Help Involvement
	Service Utilization and Cost

Working Group Roster:

WG Members:

Frank Chaloupka, PhD, Co-Chair University of Illinois at Chicago Department of Economics Chicago, IL	Patrick Flynn, PhD, Co-Chair Texas Christian University Forth Worth, TX
Redonna Chandler, PhD National Institute on Drug Abuse (NIDA) Rockville, MD	Michael Dennis, PhD Chestnut Health Systems Bloomington, IL
Dionne Godette, PhD National Institute on Alcohol Abuse and Alcoholism (NIAAA) Bethesda, MD	Ed Nunes, PhD Columbia University Medical Center New York, NY
Rosalie Pacula, PhD RAND Corporation Santa Monica, CA	Kay L. Wanke, PhD, MPH Office of Disease Prevention (ODP) Tobacco Regulatory Science Program Rockville, MD

Substance Abuse and Addiction Panel Liaison, WG Manager and WG Supervisor:

Andrea Hussong, PhD, SAA Scientific Panel Liaison University of North Carolina at Chapel Hill Chapel Hill, NC	Paul Wakim, PhD, SAA Scientific Panel Liaison National Institute on Drug Abuse (NIDA) Rockville, MD
Tabitha P. Hendershot, BA, WG Supervisor RTI International Washington, DC	Destiney Nettles, MPM, WG Manager RTI International Research Triangle Park, NC

Supplemental Information includes protocols that the Working Group or Expert Review Panel considered useful and highly relevant to the domain but do not meet the criteria for inclusion in the Toolkit.

Substance Use-related Co-morbidities and Health-related Supplemental Information includes:

• SI Medical Conditions
• SI PersonalHealthStatus

Additional Information:

There is no additional information for this collection.

Measure		Protocols	Domain/Collection
Behavioral Health Screener	Add to My Toolkit	Behavioral Health Screener	Substance Use-related Co-morbidities and Health-related Outcomes
Comprehensive HIV Risk Assessment	Add to My Toolkit	Comprehensive HIV Risk Assessment	Substance Use-related Co-morbidities and Health-related Outcomes
Duration of Abstinence	Add to My Toolkit	Duration of Abstinence - Alcohol	Substance Use-related Co-morbidities and Health-related Outcomes
	Add to My Toolkit	Duration of Abstinence - Substance Use	Substance Use-related Co-morbidities and Health-related Outcomes
Health Quality Index for Economic Evaluations	Add to My Toolkit	Health Quality Index for Economic Evaluations - Adult	Substance Use-related Co-morbidities and Health-related Outcomes
	Add to My Toolkit	Health Quality Index for Economic Evaluations - Child and Adolescent	Substance Use-related Co-morbidities and Health-related Outcomes
Self-Help Involvement	Add to My Toolkit	Self-Help Involvement	Substance Use-related Co-morbidities and Health-related Outcomes
Service Utilization and Cost	Add to My Toolkit	Service Utilization and Cost	Substance Use-related Co-morbidities and Health-related Outcomes
Substance Abuse Treatment, Participation, and Involvement	Add to My Toolkit	Substance Abuse Treatment, Participation, and Involvement	Substance Use-related Co-morbidities and Health-related Outcomes
Victimization Screener	Add to My Toolkit	Victimization Screener	Substance Use-related Co-morbidities and Health-related Outcomes